Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative Duloxetine for Prevention of Chronic Postsurgical Pain After Inguinal Hernia Repair
2023-505860-12-00Phase 3Authorised
- Sponsor
- Parc de Salut Mar
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Persistent postsurgical pain (PPSP) comparing Duloxetine arm with Placebo arm (2 arms). Primary endpoint: Incidence of chronic postsurgical pain at 4 months. Planned start Sep 2023; status: authorised.
02
Drugs
duloxetine
03
Conditions
Persistent postsurgical pain (PPSP)
Beyond the preview
Go deeper on 2023-505860-12-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-505860-12-00.